As of 30 Sep 2025, 54 institutional investors reported holding $1,201,059,099 in principal (par value) of DEXCOM INC - NOTE 0.250%11/1.
| Period | Principal | Value | Change | Price (% of par) (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | $0 | $0 | -$36,603 | 0 | |
| 2025 Q3 | $1,201,059,099 | $1,117,443,006 | +$15,252,610 | 99.3% | 54 |
| 2025 Q2 | $1,167,328,550 | $1,152,506,640 | +$2,034,006 | 98.12% | 55 |
| 2025 Q1 | $1,172,568,237 | $1,142,540,195 | +$42,247,255 | 97.33% | 62 |
| 2024 Q4 | $1,187,376,050 | $1,144,950,630 | -$53,824,783 | 96.25% | 78 |
| 2024 Q3 | $1,204,953,877 | $1,149,454,611 | +$46,723,561 | 95.35% | 82 |
| 2024 Q2 | $1,151,558,262 | $1,154,239,614 | +$19,421,344 | 100.06% | 90 |
| 2024 Q1 | $1,125,461,225 | $1,243,933,105 | -$6,048,819,787 | 109.85% | 88 |
| 2023 Q4 | $189,700,000 | $198,974,925 | -$31,433,285 | 104.65% | 2 |
| 2023 Q3 | $911,359,567 | $872,464,887 | +$106,915,071 | 94.4% | 87 |
| 2023 Q2 | $796,354,160 | $863,135,501 | -$39,349,470 | 106.75% | 70 |
| 2023 Q1 | $839,294,160 | $905,669,784 | +$2,610,630 | 107.12% | 67 |
| 2022 Q4 | $836,879,960 | $921,896,379 | +$23,221,301 | 108.76% | 70 |
| 2022 Q3 | $826,515,060 | $726,293,015 | -$362,929,613 | 92.19% | 64 |
| 2022 Q2 | $1,224,542,170 | $1,090,412,530 | -$32,279,580 | 91.5% | 61 |
| 2022 Q1 | $1,280,340,562 | $1,435,464,847 | +$121,177,301 | 114.59% | 62 |
| 2021 Q4 | $1,182,006,252 | $1,382,887,608 | +$417,334,318 | 118.69% | 60 |
| 2021 Q3 | $850,716,690 | $1,018,584,000 | -$423,096,046 | 118.86% | 57 |
| 2021 Q2 | $951,471,770 | $1,070,083,731 | +$1,067,525,117 | 104.6% | 55 |